Clinical Trial Update: Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) [Phase 3]

View source ↗

Summary

Phase 3 REDUAL-PCI trial evaluating dabigatran-based dual therapy versus warfarin-based triple therapy in patients with atrial fibrillation undergoing percutane…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation, Percutaneous Coronary Intervention | Phase 3 | Status: COMPLETED | Results posted: 2018-07-31